2,3-Dimethylphenylpiperazine
2,3-Dimethylphenylpiperazine is a monoamine releasing agent and designer drug of the phenylpiperazine family. It acts as a partial serotonin–norepinephrine releasing agent, with values of 24 to 26nM for serotonin, 13.7 to 56nM for norepinephrine, and 1,207 to 1,320nM for dopamine. Its possible activities at serotonin receptors were not reported. The drug was first described in the scientific literature by 2009.